Status:
RECRUITING
STIMPulseControl Ancillary Speech Study
Lead Sponsor:
Steffen Paschen
Collaborating Sponsors:
Czech Technical University in Prague
Insel Gruppe AG, University Hospital Bern
Conditions:
Parkinson Disease
Impulse Control Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Speech assessment is a substudy to the STIMPulseControl study (hereinafter referred to as the main study), where audio recordings of patients voices will be recorded as part of a speech analysis in th...
Detailed Description
Speech of all study patients enrolled in the STIMPulseControl main study will be recorded at three points of time in a standardized way. Following this ancillary protocol, patients speech will be reco...
Eligibility Criteria
Inclusion
- Please refer to main study (STIMPulseControl KKS-313)
Exclusion
- Please refer to main study (STIMPulseControl KKS-313)
Key Trial Info
Start Date :
September 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 15 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06561919
Start Date
September 5 2024
End Date
July 15 2028
Last Update
December 2 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Cologne
Cologne, Germany
2
University Hospital Carl Gustav Carus
Dresden, Germany
3
University Hospital Duesseldorf
Düsseldorf, Germany
4
University Medical Center Hamburg-Eppendorf
Hamburg, Germany